Loading organizations...
Based in Singapore, AWAK Technologies is a medical technology company developing ultra-portable and wearable dialysis machines for patients with end-stage renal disease. The enterprise utilizes patented sorbent technology to continuously regenerate dialysis fluid, enabling individuals to undergo automated peritoneal dialysis at home without relying on stationary equipment. Led by chief executive officer Suresha Venkataraya, the venture-backed device developer has secured over 60 million dollars in total funding to support ongoing clinical trials and commercialization efforts. This capital accumulation includes a 40 million dollar Series B round and a 20 million dollar Series C financing supported by prominent investors like Vickers Venture Partners, Advanced MedTech, Lion City Capital, and Baxter Healthcare. The organization was founded in April 2007 by Gordon Ku, David Lee, and Martin Roberts to improve the daily lives of kidney disease patients.
AWAK Technologies has raised $71.2M across 3 funding rounds.
AWAK Technologies has raised $71.2M in total across 3 funding rounds.
AWAK Technologies has raised $71.2M in total across 3 funding rounds.
AWAK Technologies's investors include Irene Guo, Mhamed Mengad, CFA, Abel Ang, Eckuity Capital, Dr. Jeffrey Chi, Ted Tan, Advanced MedTech.
AWAK Technologies has raised $71.2M across 3 funding rounds. Most recently, it raised $20.0M Series B in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 13, 2023 | $20M Series B | Irene GUO, Mhamed Mengad, CFA | Abel ANG, Eckuity Capital | Announced |
| Dec 13, 2019 | $40M Venture Round | DR. Jeffrey CHI | Abel ANG, TED TAN | Announced |
| Dec 1, 2016 | $11.2M Venture Round | Advanced MedTech | — | Announced |
